STEPHANIE GLADDEN: Open Payments
NPI 1730119447 · MARTINSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,967 in 97 payments from 23 companies in 2025. Trend: 2023 $1,453 · 2024 $1,654 · 2025 $1,967
Food & beverage: $1,967
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $289 |
| AstraZeneca Pharmaceuticals LP | 9 | $232 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $151 |
| Amgen Inc. | 8 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $140 |
| ABBVIE INC. | 8 | $139 |
| Exact Sciences Corporation | 4 | $108 |
| GlaxoSmithKline, LLC. | 5 | $104 |
| Novo Nordisk Inc | 6 | $93 |
| Astellas Pharma US Inc | 4 | $87 |
Products named: JARDIANCE, CAPLYTA, OTEZLA, AIRSUPRA, Kerendia, MOUNJARO, VRAYLAR, Veozah.
Industry payments across WV — which companies pay providers there.
